title: The insulin-like growth factor system and its receptors: A potential novel anticancer target.
abstract: The current generation of novel anticancer therapies that are in preclinical and clinical development are based on exploiting our increasing understanding of the molecular and cellular basis of cancer development and progression. Accelerated rates of cell division and proliferation have been postulated to predispose to the development of malignant disease. The insulin-like growth factor (IGF) signaling system has an important physiological role in regulating cellular proliferation and apoptosis. This function has led to considerable interest in its relevance to neoplasia over the last decade. In this review, we give an overview of the IGF system physiology, discuss the epidemiological significance of IGF signaling and neoplasia, and review the preclinical and clinical studies in targeting IGF receptors as cancer therapies.
authors.affiliation: Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom;
authors.forename: Colin R
authors.initials: CR
authors.lastname: Lindsay
authors.forename: Tr Jeffry
authors.initials: TJ
authors.lastname: Evans
references.citation: J Natl Cancer Inst. 1999 Dec 1;91(23):2052
references.pmid: 10580039
references.citation: Cancer Res. 1998 Aug 1;58(15):3353-61
references.pmid: 9699666
references.citation: Nat Rev Cancer. 2004 Jul;4(7):505-18
references.pmid: 15229476
references.citation: Carcinogenesis. 2006 Dec;27(12):2464-8
references.pmid: 16777984
references.citation: Br J Cancer. 2006 Feb 27;94(4):465-8
references.pmid: 16450000
references.citation: Cancer Res. 2005 Dec 1;65(23):11118-28
references.pmid: 16322262
references.citation: J Biol Chem. 1997 Dec 5;272(49):31163-71
references.pmid: 9388270
references.citation: Mol Cell Endocrinol. 1997 May 16;129(2):121-6
references.pmid: 9202395
references.citation: Science. 1997 May 23;276(5316):1268-72
references.pmid: 9157888
references.citation: Lancet. 1998 Aug 8;352(9126):489
references.pmid: 9708783
references.citation: Clin Cancer Res. 2007 Sep 15;13(18 Pt 2):5549s-5555s
references.pmid: 17875788
references.citation: Mol Cell Biol. 1994 Jun;14(6):3604-12
references.pmid: 8196606
references.citation: Int J Cancer. 1991 Aug 19;49(1):114-7
references.pmid: 1874564
references.citation: Clin Cancer Res. 2005 Mar 1;11(5):2063-73
references.pmid: 15756033
references.citation: Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):84-9
references.pmid: 12582016
references.citation: Endocr Rev. 2000 Jun;21(3):215-44
references.pmid: 10857553
references.citation: Am J Physiol Endocrinol Metab. 2000 Jun;278(6):E967-76
references.pmid: 10826997
references.citation: Clin Cancer Res. 2007 May 1;13(9):2795-803
references.pmid: 17473213
references.citation: Gut. 2002 May;50(5):642-6
references.pmid: 11950809
references.citation: Eur J Cancer. 1993;29A(4):492-7
references.pmid: 8435198
references.citation: Cancer Immunol Immunother. 2007 Mar;56(3):343-57
references.pmid: 16832681
references.citation: Cancer Lett. 2003 Jun 10;195(2):127-37
references.pmid: 12767520
references.citation: Endocrinol Metab Clin North Am. 1996 Sep;25(3):591-614
references.pmid: 8879988
references.citation: Life Sci. 2007 May 16;80(23):2161-2169
references.pmid: 17499312
references.citation: Clin Cancer Res. 1995 Dec;1(12):1471-8
references.pmid: 9815946
references.citation: Cancer Epidemiol Biomarkers Prev. 2002 Sep;11(9):935-8
references.pmid: 12223442
references.citation: Br J Cancer. 2003 Oct 6;89(7):1237-42
references.pmid: 14520453
references.citation: J Biol Chem. 1994 May 13;269(19):13779-84
references.pmid: 7514593
references.citation: J Clin Oncol. 2004 Aug 1;22(15):3104-12
references.pmid: 15284261
references.citation: Clin Cancer Res. 2007 Oct 1;13(19):5834-40
references.pmid: 17908976
references.citation: Cancer Res. 1999 Aug 1;59(15):3588-91
references.pmid: 10446966
references.citation: Cancer Res. 2006 Jan 1;66(1):362-71
references.pmid: 16397250
references.citation: N Engl J Med. 1987 Jul 16;317(3):137-40
references.pmid: 3299085
references.citation: Endocrinology. 1997 Mar;138(3):1355-8
references.pmid: 9048647
references.citation: Epidemiol Rev. 2001;23(1):59-66
references.pmid: 11588855
references.citation: Cancer Cell. 2004 Mar;5(3):231-9
references.pmid: 15050915
references.citation: J Cancer Res Clin Oncol. 1995;121(11):674-82
references.pmid: 7593132
references.citation: J Natl Cancer Inst. 1996 Mar 20;88(6):340-8
references.pmid: 8609642
references.citation: Science. 1988 Mar 4;239(4844):1134-7
references.pmid: 2964083
references.citation: Cancer Res. 2003 Aug 15;63(16):5073-83
references.pmid: 12941837
references.citation: J Biol Chem. 2003 May 2;278(18):15991-7
references.pmid: 12604614
references.citation: Am J Clin Nutr. 2001 Oct;74(4):549-54
references.pmid: 11566656
references.citation: JAMA. 2005 May 25;293(20):2479-86
references.pmid: 15914748
references.citation: Br J Cancer. 2002 Oct 7;87(8):876-82
references.pmid: 12373602
references.citation: Cancer Gene Ther. 2000 Mar;7(3):384-95
references.pmid: 10766344
references.citation: Int J Cancer. 2002 Sep 1;101(1):11-6
references.pmid: 12209582
references.citation: Proc Natl Acad Sci U S A. 2003 Feb 4;100(3):1250-5
references.pmid: 12538852
references.citation: Endocr Rev. 2002 Dec;23(6):824-54
references.pmid: 12466191
references.citation: J Am Geriatr Soc. 1994 Jan;42(1):71-6
references.pmid: 8277119
references.citation: Int J Cancer. 1996 Mar 15;65(6):812-20
references.pmid: 8631597
references.citation: Int J Cancer. 2008 Jan 15;122(2):267-73
references.pmid: 17918158
references.citation: Cell Growth Differ. 2002 Feb;13(2):87-93
references.pmid: 11864912
references.citation: Cell. 1993 Oct 8;75(1):59-72
references.pmid: 8402901
references.citation: J Clin Oncol. 2004 Mar 1;22(5):785-94
references.pmid: 14990633
references.citation: Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3455-60
references.pmid: 10737798
references.citation: Cancer Cell. 2004 Mar;5(3):221-30
references.pmid: 15050914
references.citation: Neoplasia. 2002 May-Jun;4(3):204-17
references.pmid: 11988840
references.citation: Proc Soc Exp Biol Med. 1998 Feb;217(2):143-52
references.pmid: 9452137
references.citation: Diabetologia. 1991 Mar;34(3):144-9
references.pmid: 1884885
references.citation: Epidemiology. 1995 Jul;6(4):423-4
references.pmid: 7548353
references.citation: J Clin Endocrinol Metab. 1996 Oct;81(10):3774-82
references.pmid: 8855837
references.citation: Mol Cancer Ther. 2007 Aug;6(8):2158-67
references.pmid: 17671083
references.citation: Oncogene. 2001 Nov 8;20(51):7542-50
references.pmid: 11709726
references.citation: Cancer Res. 2003 Feb 1;63(3):627-35
references.pmid: 12566306
references.citation: Mol Carcinog. 2003 Mar;36(3):142-6
references.pmid: 12619036
references.citation: Cell. 1991 Feb 22;64(4):849-59
references.pmid: 1997210
references.citation: Cancer Res. 1997 Nov 1;57(21):4667-72
references.pmid: 9354418
references.citation: BMJ. 2007 Dec 1;335(7630):1134
references.pmid: 17986716
references.citation: Clin Cancer Res. 2002 Oct;8(10):3259-69
references.pmid: 12374697
references.citation: Endocr Rev. 1995 Feb;16(1):3-34
references.pmid: 7758431
references.citation: Diabetes. 1996 Jan;45(1):91-100
references.pmid: 8522066
references.citation: Int J Cancer. 1994 May 15;57(4):491-7
references.pmid: 7514152
references.citation: Cancer Res. 2003 Aug 1;63(15):4384-8
references.pmid: 12907608
references.citation: Clin Cancer Res. 2007 Jun 15;13(12):3611-6
references.pmid: 17575225
references.citation: Clin Endocrinol (Oxf). 1994 Sep;41(3):351-7
references.pmid: 7955442
references.citation: J Natl Cancer Inst. 1997 Dec 3;89(23):1813-4
references.pmid: 9392625
references.citation: Cancer Res. 2003 Dec 15;63(24):8912-21
references.pmid: 14695208
references.citation: N Engl J Med. 2001 Mar 15;344(11):783-92
references.pmid: 11248153
references.citation: J Natl Cancer Inst. 2005 Nov 16;97(22):1671-9
references.pmid: 16288120
references.citation: Cancer Immunol Immunother. 2000 Jul;49(4-5):243-52
references.pmid: 10941907
references.citation: Oncology. 1999 Nov;57(4):330-40
references.pmid: 10575321
references.citation: Breast Cancer Res Treat. 1998 Feb;47(3):269-81
references.pmid: 9516081
references.citation: J Natl Cancer Inst. 2000 Sep 20;92(18):1472-89
references.pmid: 10995803
references.citation: Endocr Rev. 1995 Apr;16(2):143-63
references.pmid: 7540132
references.citation: Mol Endocrinol. 1994 Apr;8(4):510-7
references.pmid: 8052269
references.citation: Int J Cancer. 2003 Dec 20;107(6):991-6
references.pmid: 14601060
references.citation: Int J Biochem Cell Biol. 1996 Jun;28(6):619-37
references.pmid: 8673727
references.citation: Br J Cancer. 2003 Jul 7;89(1):81-7
references.pmid: 12838305
references.citation: J Immunol. 1997 Aug 1;159(3):1225-32
references.pmid: 9233617